Literature DB >> 7775114

Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis.

D C Metrikin1, C A Wilson, B A Berkowitz, M K Lam, G K Wood, R M Peshock.   

Abstract

PURPOSE: Endophthalmitis is a severe inflammatory disorder with profound visual consequences. Treatment of this disorder has been limited by the lack of quantitative information regarding retinal responses to severe inflammation. The purpose of this study was to measure the effect of endotoxin-induced endophthalmitis on blood-retinal barrier (BRB) function in vivo using contrast-enhanced magnetic resonance imaging (MRI).
METHODS: Endophthalmitis was produced by injecting Escherichia coli endotoxin into the midvitreous of pigmented rabbits. Contrast-enhanced MRI was performed at selected intervals thereafter. In all cases, a clinical grading system was used to assess the severity of inflammation before imaging. In a dose-response experiment, total vitreous protein was measured from vitreous specimens obtained 1 day after endotoxin injection and immediately after the imaging procedure.
RESULTS: At 1 day after injection, endotoxin produced a selective breakdown of the inner BRB at all doses evaluated (0.01 microgram to 500 micrograms). Permeability-surface area product normalized to the area of leaky retina (PS') increased from 1.35 +/- 0.78 x 10(-4) cm/minute (mean +/- SEM, n = 4 eyes) at a dose of 0.01 microgram to 8.15 +/- 2.22 x 10(-4) cm/minute n = 4) eyes) at a dose of 10 micrograms. Inner BRB integrity was restored by day 28 after injection. In general, changes in PS', blood-aqueous barrier leakage, mean clinical score, and vitreous protein concentration were found, but the correlation between any two of these parameters was poor.
CONCLUSION: Leakage of contrast appears early in the course of endotoxin-induced endophthalmitis and is a self-limited process. In future studies, these quantifiable changes in BRB permeability should prove useful in the assessment of various therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775114

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Minimum endotoxin concentration causing inflammation in the anterior segment of rabbit eyes.

Authors:  Akira Sakimoto; Mitsuru Sawa; Taiki Oshida; Satoshi Sugaya; Taisuke Hirono; Akiko Ishimori
Journal:  Jpn J Ophthalmol       Date:  2009-09-08       Impact factor: 2.447

2.  Sirolimus-Loaded Intravitreal Implant for Effective Treatment of Experimental Uveitis.

Authors:  Mayara Rodrigues Brandão De Paiva; Daniel Vítor Vasconcelos-Santos; Lorena Carla Vieira; Sílvia Ligório Fialho; Armando Silva-Cunha
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

3.  The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Zachary M Robertson; Quincy C Moore; Jonathan Fratkin; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

4.  Associated factors and treatment outcome of presumed noninfectious endophthalmitis occurring after intravitreal triamcinolone acetonide injection.

Authors:  Seong Joon Ahn; Tae Wan Kim; Jeeyun Ahn; Jang Won Huh; Hyeong Gon Yu; Hum Chung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-22       Impact factor: 3.117

Review 5.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study.

Authors:  T Das; S Jalali; V K Gothwal; S Sharma; T J Naduvilath
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

7.  Markers of cochlear inflammation using MRI.

Authors:  Johann Le Floc'h; Winston Tan; Ravindra S Telang; Srdjan M Vlajkovic; Alfred Nuttall; William D Rooney; Beau Pontré; Peter R Thorne
Journal:  J Magn Reson Imaging       Date:  2013-04-15       Impact factor: 4.813

Review 8.  Clinical application of MRI in ophthalmology.

Authors:  Kelly A Townsend; Gadi Wollstein; Joel S Schuman
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

Review 9.  MRI in ocular drug delivery.

Authors:  S Kevin Li; Martin J Lizak; Eun-Kee Jeong
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

10.  Bacillus cereus induces permeability of an in vitro blood-retina barrier.

Authors:  A L Moyer; R T Ramadan; J Thurman; A Burroughs; M C Callegan
Journal:  Infect Immun       Date:  2008-02-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.